Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Sleep Wake Disorders 1Memory Disorders 1Fatigue 1Depression 1Cognitive Dysfunction 1Cognition Disorders 1Anxiety Disorders 1

Interventions

Psychiatric Rehabilitation 5Music Therapy 5Cognitive Behavioral Therapy 4Yoga 3Therapeutics 3Surveys and Questionnaires 3Saline Solution 3Mindfulness-Based Cognitive Therapy 3Mindfulness 3Methods 3Esketamine 3Standard of Care 2Mindfulness-Based Stress Reduction 2Hypnosis 2Educational Status 2Early Intervention, Educational 2Counseling 2Acupuncture Therapy 2Acceptance and Commitment Therapy 2Virtual Reality Exposure Therapy 1Self-Management 1Self-Help Groups 1Psychosocial Intervention 1Professional Autonomy 1Postoperative Period 1Population Groups 1Neoadjuvant Therapy 1Minocycline 1Melatonin 1Massage 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anxiety Disorders × Donepezil × Breast × Clear all
NCT01466270 2021-10-20

Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction

Wake Forest University Health Sciences

Phase 2 Completed
62 enrolled 12 charts
Breast

Anxiety Disorders, Breast Neoplasms, Cognition Disorders, Depression, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡